http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2301676-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cc98ef872822d651f3443bf7f774aa4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 2005-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2babf5818f1eb2819d474f44546bfe4f |
| publicationDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2301676-C1 |
| titleOfInvention | Method for treatment of joint complications of rheumatic diseases |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to a method for treatment of locomotor system, in particular, treatment of joint complications of rheumatic diseases. Method involves intra-osseous administration of solcoseryl or actovegin solution in volume 2-5 ml by course 5-10 procedures, 2 times per a week, wherein 1 ml is administrated at the rate 0.017-0.015 ml/s, and other volume is administrated in equal parts wherein the rate administration of the first part is 0.02-0.017 ml/s and the second one - 0.061-0.1 ml/s. Method provides effective treatment based on retaining high concentration of drug by indicated administration regimen in osseous tissue for prolonged time. n EFFECT: enhanced effectiveness of treatment. n 2 cl, 1 tbl, 5 ex |
| priorityDate | 2005-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.